Signal return
—
Price move
+5.29%（$3.07）
First included
2026-08-04
Inclusion price
$58.04
Latest brief price
$61.11
Methodology: each issue's direction is a live signal — long/short opens or holds a position, neutral means flat, and every direction change opens, flips, or closes it. Returns are direction-aware (a short gains when the price falls) and compound across positions from first observation to the latest issue. "Price move" is the stock's own raw change, shown separately. Neither represents actual portfolio performance.
Brief History (2 issues)
August 5, 2026NeutralRapid scan5/10$61.11+5.29%
Up 5.29% to a 52-week high with RSI(7) extremely overbought at 84.4 after a 15.6% week; a clinical-stage name with no fundamental anchor; sidelines.
August 4, 2026NeutralRapid scan5/10Free preview$58.04+5.89%
Up 5.89% to a 52-week high on 4.07x relative volume with RSI at 70.2 — a clinical-stage biotech breakout with no fundamental anchor; sidelines.